13th European AIDS Conference

October 12-15, 2011 - Belgrade, Serbia

EACS 2011: Neurocognitive Impairment in People with HIV

How much more common is brain impairment and dementia in people with HIV than in the general population? A study presented at the 13th European AIDS Conference (EACS 2011) this week in Belgrade showed that the answer could vary from "no more common" to "4 times as common," according to which group you studied, which sample of the HIV negative population you compared them with, and whether you averaged their neurocognitive (NC) performance over all domains or picked out specific areas of impairment.

Read more:

EACS 2011: Raltegravir Demonstrates Continued Efficacy at 4 Years

People taking the HIV integrase inhibitor raltegravir (Isentress) continued to show good viral suppression with few side effects at 192 weeks after starting antiretroviral therapy (ART) for the first time, researchers reported at the 13th European AIDS Conference (EACS 2011) this week in Belgrade.alt

Read more:

EACS 2011: Do Women with HIV Experience Earlier Menopause?

Premature menopause may be more common among women with HIV, but the difference is primarily driven by women with advanced immune deficiency, according to study results presented at the 13th European AIDS Conference (EACS 2011) this week in Belgrade.alt

Read more:

EACS 2011: People on Methadone Maintenance Can Be Successfully Treated for Hepatitis C

Opiate users on methadone maintenance therapy can be successfully treated for chronic hepatitis C virus (HCV) infection and can achieve outcomes similar to those of patients not on methadone, according to data presented at the 13th European AIDS Conference (EACS 2011) this week in Belgrade.alt

Read more: